Back to Search
Start Over
Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
- Source :
-
Early intervention in psychiatry [Early Interv Psychiatry] 2019 Jun; Vol. 13 (3), pp. 589-597. Date of Electronic Publication: 2017 Dec 12. - Publication Year :
- 2019
-
Abstract
- Aim: Early clinical response predicts symptomatic remission and recovery in the maintenance treatment phase of first-episode schizophrenia (FES). However, little is known about predictors of symptomatic remission during acute treatment of severely ill patients with FES. Here, we conducted a secondary analysis of our retrospective observational study, which examined response, remission and treatment-resistance rates in seriously ill patients with FES spectrum disorders involuntarily hospitalized and treated with algorithm-based pharmacotherapy.<br />Methods: We performed a retrospective chart review of 131 involuntarily admitted patients with schizophrenia or schizoaffective disorder. Our algorithm aimed to delay olanzapine treatment, standardize medications and suggest initiation of clozapine after failure of third-line antipsychotic treatment. The duration of each adequate antipsychotic treatment at an optimal dosage was 4 weeks or more. Remission was defined using the symptom-severity component of consensus remission criteria. A logistic regression model was applied to identify significant predictors of remission at discharge.<br />Results: Overall, 74 patients (56%) were in remission at discharge. Non-remitters were hampered from becoming remitters mainly by the presence of negative symptoms. There were no differences in first-line antipsychotics, dosage of antipsychotics at time of response and adherence rates to algorithm-based pharmacotherapy between remitters and non-remitters. Shorter duration of untreated psychosis, favourable early response and less negative symptoms at baseline were identified as independent predictors of remission at discharge.<br />Conclusions: The importance of early intervention and specific and adequate treatments of negative symptoms is highlighted.<br /> (© 2017 John Wiley & Sons Australia, Ltd.)
- Subjects :
- Administration, Oral
Adult
Antipsychotic Agents adverse effects
Clozapine adverse effects
Clozapine therapeutic use
Drug Therapy, Combination
Female
Haloperidol adverse effects
Haloperidol therapeutic use
Humans
Injections, Intramuscular
Male
Methotrimeprazine adverse effects
Methotrimeprazine therapeutic use
Olanzapine adverse effects
Olanzapine therapeutic use
Psychotic Disorders diagnosis
Psychotic Disorders psychology
Quetiapine Fumarate adverse effects
Quetiapine Fumarate therapeutic use
Retrospective Studies
Risperidone adverse effects
Risperidone therapeutic use
Schizophrenia diagnosis
Treatment Failure
Treatment Outcome
Algorithms
Antipsychotic Agents therapeutic use
Commitment of Mentally Ill
Psychotic Disorders drug therapy
Schizophrenia drug therapy
Schizophrenic Psychology
Subjects
Details
- Language :
- English
- ISSN :
- 1751-7893
- Volume :
- 13
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Early intervention in psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 29498481
- Full Text :
- https://doi.org/10.1111/eip.12531